[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$2373b](/topic/$2373b) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "@Investingcom Johnson & Johnson crushing it again. That $23.73B revenue is a flex especially after all the legal noise lately. Big pharma stays winning" [@BuckyDroid](/creator/x/BuckyDroid) on [X](/post/tweet/1945463959144058974) 2025-07-16 12:42:07 UTC 4004 followers, XX engagements "@Investingcom Johnson & Johnson's Q2 earnings beat estimates with EPS of $XXXX vs. $XXXX expected and revenue of $23.73B surpassing $22.86B estimates driven by diversified growth despite Stelara biosimilar pressures; they also raised full-year guidance signaling strong momentum" [@MateBarzo](/creator/x/MateBarzo) on [X](/post/tweet/1945440752504619321) 2025-07-16 11:09:54 UTC XXX followers, XX engagements "📢 BREAKING: Johnson & Johnson reports strong Q2 results: EPS: $XXXX vs. $XXXX est. Revenue: $23.73B vs. $22.86B est. $JNJ" [@DanielMorganX1](/creator/x/DanielMorganX1) on [X](/post/tweet/1945435199879156200) 2025-07-16 10:47:50 UTC 3621 followers, XXX engagements "Johnson & Johnson beats estimates on both EPS and revenue. But remember earnings are just one piece of the puzzle. Watch how the market reacts today" [@007ofWallSt](/creator/x/007ofWallSt) on [X](/post/tweet/1945432630226235673) 2025-07-16 10:37:38 UTC 6042 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@Investingcom Johnson & Johnson crushing it again. That $23.73B revenue is a flex especially after all the legal noise lately. Big pharma stays winning"
@BuckyDroid on X 2025-07-16 12:42:07 UTC 4004 followers, XX engagements
"@Investingcom Johnson & Johnson's Q2 earnings beat estimates with EPS of $XXXX vs. $XXXX expected and revenue of $23.73B surpassing $22.86B estimates driven by diversified growth despite Stelara biosimilar pressures; they also raised full-year guidance signaling strong momentum"
@MateBarzo on X 2025-07-16 11:09:54 UTC XXX followers, XX engagements
"📢 BREAKING: Johnson & Johnson reports strong Q2 results: EPS: $XXXX vs. $XXXX est. Revenue: $23.73B vs. $22.86B est. $JNJ"
@DanielMorganX1 on X 2025-07-16 10:47:50 UTC 3621 followers, XXX engagements
"Johnson & Johnson beats estimates on both EPS and revenue. But remember earnings are just one piece of the puzzle. Watch how the market reacts today"
@007ofWallSt on X 2025-07-16 10:37:38 UTC 6042 followers, XXX engagements
/topic/$2373b/posts